» Articles » PMID: 12547394

HSMUG1 Can Functionally Compensate for Ung1 in the Yeast Saccharomyces Cerevisiae

Overview
Publisher Elsevier
Date 2003 Jan 28
PMID 12547394
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There are at least four distinct families of enzymes that recognize and remove uracil from DNA. Family-3 (SMUG1) enzymes have recently been identified and have a preference for uracil in single-stranded DNA when assayed in vitro. Here we investigate the in vivo function of SMUG1 using the yeast Saccharomyces cerevisiae as a model system. These organisms lack a SMUG1 homologue and use a single enzyme, Ung1 to carry out uracil-repair. When a wild-type strain is treated with antifolate agents to induce uracil misincorporation into DNA, S-phase arrest and cellular toxicity occurs. The arrest is characteristic of checkpoint activation due to single-strand breaks caused by continuous uracil removal and self-defeating DNA repair. When uracil-DNA glycosylase is deleted (deltaung1), cells continue through S-phase and arrest at G(2)/M, presumably due to the effects of stable uracil misincorporation in DNA. Pulsed field gel electrophoresis (PFGE) demonstrates that cells are able to complete DNA replication with uracil-substituted DNA and do not experience the extensive strand breakage attributed to uracil-DNA glycosylase-mediated repair. As a result, these cells experience early protection from antifolate-induced cytotoxicity. When either UNG1 or SMUG1 functions are reintroduced back into the null strain and then subjected to antifolate treatment, the cells revert back to the wild-type phenotype as shown by a restored sensitivity to drug and S-phase arrest. The arrest is accompanied by the accumulation of replication intermediates as determined by PFGE. Collectively, these data indicate that SMUG1 can act as a functional homolog of the family-1 uracil-DNA glycosylase enzymes.

Citing Articles

The base excision repair process: comparison between higher and lower eukaryotes.

Hindi N, Elsakrmy N, Ramotar D Cell Mol Life Sci. 2021; 78(24):7943-7965.

PMID: 34734296 PMC: 11071731. DOI: 10.1007/s00018-021-03990-9.


Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments.

Palinkas H, Bekesi A, Rona G, Pongor L, Papp G, Tihanyi G Elife. 2020; 9.

PMID: 32956035 PMC: 7505663. DOI: 10.7554/eLife.60498.


Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung-/-Msh2-/- mice.

Kemmerich K, Dingler F, Rada C, Neuberger M Nucleic Acids Res. 2012; 40(13):6016-25.

PMID: 22447450 PMC: 3401444. DOI: 10.1093/nar/gks259.


Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms.

Pettersen H, Sundheim O, Gilljam K, Slupphaug G, Krokan H, Kavli B Nucleic Acids Res. 2007; 35(12):3879-92.

PMID: 17537817 PMC: 1919486. DOI: 10.1093/nar/gkm372.


Mitochondrial inhibition of uracil-DNA glycosylase is not mutagenic.

Kachhap S, Singh K Mol Cancer. 2004; 3:32.

PMID: 15574194 PMC: 538255. DOI: 10.1186/1476-4598-3-32.